Storage Condition
Refer MSDS for complete information
Application Notes
Useful research chemical for a range of applications
Hazard Compound
Refer MSDS for complete information
Almotriptan D3 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Almotriptan D3 usage and description
Almotriptan D3 is a medication used to treat acute migraine headaches. It is a triptan class drug that works by narrowing blood vessels in the brain, thereby relieving the pain and other symptoms associated with migraines. Almotriptan D3 is a deuterated version of almotriptan, meaning that three hydrogen atoms in its chemical structure have been replaced with deuterium atoms. This makes it more stable and increases its bioavailability, allowing for a more consistent and effective treatment of migraines.
The chemical formula of Almotriptan D3 is C17H19N3O2S2D3, and its molecular weight is 354.53 g/mol. It is administered orally in tablet form, with a typical dose of 12.5 mg. It has a half-life of approximately 3-4 hours and is metabolized in the liver.
Almotriptan D3 is contraindicated in patients with severe liver or kidney disease, uncontrolled high blood pressure, or a history of heart disease. It should also not be taken concomitantly with other triptans or ergotamine-containing medications.
In conclusion, Almotriptan D3 is a potent and effective medication for the treatment of acute migraine headaches. Its deuterated form enhances its stability and bioavailability, making it a reliable and consistent option for migraine sufferers. However, it should be used with caution and under the guidance of a healthcare professional.
